APA (7th ed.) Citation

Živić, K., Pavlović, M., Ostojić, M., Galun, D., Pavić, A., Srdić-Rajić, T., & Grahovac, J. (2026). Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma. Cells (2073-4409), 15(11), 1032. https://doi.org/10.3390/cells15111032

Chicago Style (17th ed.) Citation

Živić, Kristina, Marijana Pavlović, Marija Ostojić, Danijel Galun, Aleksandar Pavić, Tatjana Srdić-Rajić, and Jelena Grahovac. "Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma." Cells (2073-4409) 15, no. 11 (2026): 1032. https://doi.org/10.3390/cells15111032.

MLA (9th ed.) Citation

Živić, Kristina, et al. "Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma." Cells (2073-4409), vol. 15, no. 11, 2026, p. 1032, https://doi.org/10.3390/cells15111032.